Semaphorin 6B as a novel glucose-lowering hormone to counteract type 2 diabetes: molecular mechanism and clinical implications

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Semaphorin 6B as a novel glucose-lowering hormone to counteract type 2 diabetes: molecular mechanism and clinical implications
Principal Investigator
Dr Wang, Baile   (Principal Investigator (PI))
Co-Investigator(s)
Professor Xu Aimin   (Co-Investigator)
Duration
36
Start Date
2025-01-01
Amount
1558606
Conference Title
Semaphorin 6B as a novel glucose-lowering hormone to counteract type 2 diabetes: molecular mechanism and clinical implications
Keywords
Semaphorin 6B, glucose-lowering effect, type 2 diabetes, insulin sensitivity, gluconeogenesis
Discipline
Diabetes/MetabolismEndocrinology
Panel
Biology and Medicine (M)
HKU Project Code
17117724
Grant Type
General Research Fund (GRF) 2024/25
Funding Year
2024
Status
On-going
Objectives
Refer to ES